Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/4105
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVisvanathan, S.-
dc.contributor.authorDeodhar, A.-
dc.contributor.authorBraun, J.-
dc.contributor.authorVAN DER HEIJDE, Desiree-
dc.contributor.authorYan, S.-
dc.contributor.authorGathany, T.-
dc.contributor.authorGEUSENS, Piet-
dc.contributor.authorWilliamson, P.-
dc.contributor.authorWagner, C.-
dc.date.accessioned2007-12-10T10:03:06Z-
dc.date.available2007-12-10T10:03:06Z-
dc.date.issued2006-
dc.identifier.citationANNALS OF THE RHEUMATIC DISEASES, 65. p. 547-547-
dc.identifier.issn0003-4967-
dc.identifier.urihttp://hdl.handle.net/1942/4105-
dc.language.isoen-
dc.publisherB M J PUBLISHING GROUP-
dc.titleModulation of biomarkers of inflammation and bone turnover and associations with bone mineral density in ankylosing spondylitis (AS) patients treated with infliximab-
dc.typeJournal Contribution-
dc.identifier.epage547-
dc.identifier.spage547-
dc.identifier.volume65-
local.format.pages1-
local.bibliographicCitation.jcatM-
dc.description.notesOregon Hlth & Sci Univ, Portland, OR 97201 USA. Rheumazentrum Ruhrgebiet, Herne, Germany. Univ Hosp Maastricht, Maastricht, Netherlands. Centocor Inc, Res & Dev, Malvern, PA 19355 USA. Univ Hasselt, Diepenbeek, Belgium.-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
dc.bibliographicCitation.oldjcatA5-
dc.identifier.isi000249372502261-
item.fulltextNo Fulltext-
item.contributorVisvanathan, S.-
item.contributorDeodhar, A.-
item.contributorBraun, J.-
item.contributorVAN DER HEIJDE, Desiree-
item.contributorYan, S.-
item.contributorGathany, T.-
item.contributorGEUSENS, Piet-
item.contributorWilliamson, P.-
item.contributorWagner, C.-
item.fullcitationVisvanathan, S.; Deodhar, A.; Braun, J.; VAN DER HEIJDE, Desiree; Yan, S.; Gathany, T.; GEUSENS, Piet; Williamson, P. & Wagner, C. (2006) Modulation of biomarkers of inflammation and bone turnover and associations with bone mineral density in ankylosing spondylitis (AS) patients treated with infliximab. In: ANNALS OF THE RHEUMATIC DISEASES, 65. p. 547-547.-
item.accessRightsClosed Access-
crisitem.journal.issn0003-4967-
crisitem.journal.eissn1468-2060-
Appears in Collections:Research publications
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.